LSALT Peptide (Metablok) Scientists
LSALT Peptide (Metablok) team – lead scientists
Dr. Stephen Robbins Ph. D
Dr. Robbins is currently a Professor at the University of Calgary in the Departments of Oncology and Biochemistry & Molecular Biology. He is a former Canada Research Chair in Cancer Biology, and is an AHFMR Scientist. Dr. Robbins obtained his Ph. D from the University of British Columbia in 1991 and pursued postdoctoral training at the University of California, San Francisco, under the mentorship of Nobel Laureate Dr. J. Michael Bishop. His current research interests are in the area of developing novel therapeutics for cancer with a specific focus on brain tumours.
Dr. Donna Senger Ph. D
Dr. Senger obtained her PhD in the Department of Cell Biology at the University of Alberta. During her Ph. D studies she published a seminal paper in her field that described a novel signaling process in sympathetic neurons where nerve growth factor (NGF) induces a rapidly propagated signal that does not require vesicular transport of NGF. In 2000, Dr. Senger moved to the University of Calgary where she helped to establish a multi-disciplinary translational research group. Dr. Senger’s research has focused on numerous aspects of both primary and metastatic brain cancer with an emphasis on understanding brain tumour progression for the development of new treatments.
